ACP-105, a novel non-steroidal SARMs. It is shown to be as potent and efficacious as test in in vitro assays without interaction at other hormone receptors. Moreover, ACP-105 demonstrates potent anabolic effects on muscle and bone with minimal effect on prostrate in preclinical models.